---
title: CuriRx, Inc. vs STC Biologics
slug_a: curirx
slug_b: stcbiologics
site: cro
review_signal_gate: closed
canonical_path: /compare/curirx/stcbiologics
---

# CuriRx, Inc. vs STC Biologics

Side-by-side profile data from each company listing on this directory.

## CuriRx, Inc.

- Profile: [/companies/curirx](/companies/curirx)

CuriRx, Inc. — CuriRx, Inc. is a Wilmington, Massachusetts contract research and development organization. It offers formulation development, prefilled syringe and lyophilization services, bioprocessing, and analytical testing to pharmaceutical companies of all sizes.

Services: 13. Modalities: 3. Indications: 0. Locations: 2. Certifications: 0. The strongest documented coverage currently appears in services (13).

### Services

- Analytical Method Development & Validation
- ICH Stability Studies
- Cell-Line Development
- Upstream Processing
- Downstream Processing
- Prefilled Syringe (PFS) Filling
- Lyophilization (Freeze Drying)
- Process Development
- Formulation Development
- CMC Analytical Development
- Quality Control Testing
- Stability Testing & Storage
- CMC Regulatory Submission Support

### Modalities

- Small Molecule
- Biologics (Other)
- Gene Therapy

### Indications

- Data not yet provided.

### Phases

- Data not yet provided.

### Sourcing models

- Full-Service Outsourcing (FSO)

## STC Biologics

- Profile: [/companies/stcbiologics](/companies/stcbiologics)

STC Biologics — Boutique biologics CDMO with a Speed-to-Clinic platform spanning royalty-free cell line development through cGMP drug substance, in as little as 12 months. Runs a single-use mammalian GMP suite in Newton, MA for antibody, bispecific, and ADC programs.

Services: 5. Modalities: 2. Indications: 0. Locations: 1. Certifications: 0. The strongest documented coverage currently appears in services (5).

### Services

- Biologics Development & Manufacturing
- Monoclonal Antibody (mAb) Manufacturing
- Cell-Line Development
- ADC (Antibody-Drug Conjugate) Manufacturing
- CMC Regulatory Submission Support

### Modalities

- Biologics (Monoclonal Antibodies)
- Antibody-Drug Conjugate (ADC)

### Indications

- Data not yet provided.

### Phases

- Data not yet provided.

### Sourcing models

- Data not yet provided.